GlassScriptPhysician profile
Christopher B Mizelle
NPI 1568471555
$7,755.68
in general payments reported to CMS, 2019-2025
36 companies · $1,057 in 2025
The $1,057 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,300 · 2020: $248 · 2021: $917 · 2022: $1,300 · 2023: $1,502 · 2024: $1,432 · 2025: $1,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,573 · Education: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,572.94 |
| Education | $417.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,305.06 | 2019-2025 | |
| Janssen Biotech, INC. | $1,092.88 | 2021-2025 | Tremfya |
| Merz North America, INC. | $1,085.61 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $865.47 | 2019-2025 | Ilumya, Absorica Ld, Winlevi |
| Novartis Pharmaceuticals Corporation | $493.64 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $391.30 | 2021-2025 | Dupixent, Libtayo |
| Leo Pharma INC. | $350.44 | 2021-2025 | Adbry |
| Pfizer INC. | $273.50 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $215.99 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $199.65 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $166.07 | 2022-2024 | Spevigo |
| Lilly USA, LLC | $158.23 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Organogenesis INC. | $137.83 | 2023-2024 | Puraply |
| Allergan, INC. | $135.69 | 2019-2022 | |
| Prugen, INC. Pharmaceuticals | $127.48 | 2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $97.53 | 2020-2025 | Aklief, Nemluvio |
| Helsinn Therapeutics (U.S.), INC. | $89.81 | 2019-2023 | Valchlor |
| Ucb, INC. | $78.51 | 2019-2025 | Bimzelx |
| Almirall LLC | $76.40 | 2019-2022 | |
| Biofrontera INC. | $60.37 | 2019-2022 | |
| Revance Therapeutics, INC. | $58.33 | 2024 | Daxxify |
| Organon LLC | $56.30 | 2025 | Vtama |
| Genentech USA, INC. | $31.22 | 2019-2022 | |
| Botanix Sb INC | $30.51 | 2025 | Sofdra |
| Aclaris Therapeutics, INC. | $20.92 | 2019 | |
| Dermavant Sciences, INC. | $19.66 | 2023 | Vtama |
| Verrica Pharmaceuticals INC. | $18.33 | 2024 | Ycanth |
| Dusa Pharmaceuticals, INC. | $16.68 | 2019 | |
| Incyte Corporation | $16.25 | 2022 | |
| Sandoz INC. | $14.31 | 2023 | Hyrimoz |
| Vyne Pharmaceuticals INC. | $12.74 | 2020 | |
| Journey Medical Corporation | $12.44 | 2022 | |
| Strata Skin Sciences, INC. | $12.21 | 2019 | |
| Melinta Therapeutics, LLC | $11.50 | 2019 | |
| Amgen INC. | $11.48 | 2021 | |
| Taro Pharmaceuticals USA, INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Mizelle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.